Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Adel F Urmancheyeva"'
Autor:
Adel F Urmancheyeva, Alexandr V. Togo, Nadezhda Yu Krylova, Oksana S Lobeiko, Maxim E. Rozanov, Madina M. Gergova, Anna P. Sokolenko, Evgeny N. Imyanitov, Natalia V. Mitiushkina, Tatiana V Porhanova, Aglaya G. Iyevleva, Sergey Ya Maximov
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, Vol 4, Iss 4, Pp 193-196 (2006)
Hereditary Cancer in Clinical Practice, Vol 4, Iss 4, Pp 193-196 (2006)
The BRCA1 4153delA allele is frequently referred to as the Russian founder mutation, as it was initially detected in several cancer families from Moscow. Our earlier studies have demonstrated 1% occurrence of BRCA1 4153delA heterozygosity in familial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9454b5e2abf9b07b4039ebce56a4c7a9
http://europepmc.org/articles/PMC2837308
http://europepmc.org/articles/PMC2837308
Autor:
Evgeny N. Suspitsin, Evgeny N. Imyanitov, Tatyana Gorodnova, Anna P. Sokolenko, Nathalia V. Porhanova, Matsko De, Aglaya G. Iyevleva, Sergey Ya Maximov, Adel F Urmancheyeva, Daria N. Ponomariova, Grigory A Shiyanov, Alexandr V. Togo, Nathalia Yu. Sherina, Nadezhda Yu Krylova, Olga A. Zaitseva, Olga S. Yatsuk, Nathalia N. Tkachenko, Oksana S Lobeiko
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 7, Iss 1, p 5 (2009)
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice
Background A significant portion of ovarian cancer (OC) cases is caused by germ-line mutations in BRCA1 or BRCA2 genes. BRCA testing is cheap in populations with founder effect and therefore recommended for all patients with OC diagnosis. Recurrent m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb75edd948436288b842d80d8aa2018
http://www.hccpjournal.com/content/7/1/5
http://www.hccpjournal.com/content/7/1/5
Autor:
Nadezhda Yu Krylova, Adel F Urmancheyeva, Alexandr V. Togo, Natalia V Porhanova, Natalia Yu. Sherina, Evgeny N. Imyanitov, Natalia Yu Ogorodnikova, Daria N. Ponomariova, Oksana S Lobeiko, Evgeny N. Suspitsin, Denis A Logvinov, Sergey Ya Maximov
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, Vol 5, Iss 3, Pp 153-156 (2007)
Hereditary Cancer in Clinical Practice, Vol 5, Iss 3, Pp 153-156 (2007)
BRCA1 and BRCA2 germ-line mutations occur in a significant number of unselected ovarian cancer (OC) patients, thus making a noticeable contribution to OC morbidity. It is of interest whether CHEK2, which is frequently regarded as a third breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c8f739bf72abf5bb48d5503ecfb092